Actuate Therapeutics, Inc. Common stock (ACTU) — Net Asset Quality Index
Actuate Therapeutics, Inc. Common stock (ACTU) has a Net Asset Quality Index of 61.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $17.71 Million minus total liabilities of $6.78 Million yields net assets of $10.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Actuate Therapeutics, Inc. Common stock balance sheet assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Actuate Therapeutics, Inc. Common stock Net Asset Quality Index Over Time (2022–2024)
This chart shows how Actuate Therapeutics, Inc. Common stock's Net Asset Quality Index has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the index stands at 61.7%, representing net assets of $10.94 Million against total assets of $17.71 Million USD. See working capital position of Actuate Therapeutics, Inc. Common stock to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Actuate Therapeutics, Inc. Common stock (2022–2024)
The table below presents the year-by-year Net Asset Quality Index for Actuate Therapeutics, Inc. Common stock from 2022 to 2024, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ACTU stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 1.1% | $104.19K | $9.32 Million | $9.21 Million | ▲ +3326.9 pp |
| 2023 | -3325.8% | $-99.63 Million | $3.00 Million | $102.62 Million | ▼ -3398.2 pp |
| 2022 | 72.4% | $14.83 Million | $20.48 Million | $5.65 Million | — |